Autopsy report · NCT06260267
A Phase 1b Proof-of-concept Trial Exploring the Effects of FE 999322 and FE 999324 in Adults With Mild to Moderate Ulcerative Colitis
Cause of deathFunding or business
“Not due to safety concerns, but changes in strategy which this trial no longer fulfills.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 1
- Sponsor
- Ferring Pharmaceuticals
- Sponsor type
- Industry
- Conditions
- Ulcerative Colitis
- Interventions
- Microbiota suspension; Microbiota capsule; Placebo suspension; Placebo capsule
- Participants
- 0
- Sites
- 10
- Countries
- United States
Trials that died the same way
- PSMA-PET/CT Registry
“Not due to a safety concern; terminated early due to changing clinical trial landscape at centre” - A Study to Learn About the Effect of Avelumab First-Line Maintenance in Canadian People With Advanced Bladder Cancer
“The trial was terminated for strategic reasons. The decision was not based on any safety and/or efficacy concerns.” - Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH
“Trial stopped for futility” - A Dose Range Finding Study of JNJ-38518168 in Patients With Active Rheumatoid Arthritis in Spite of Treatment With Methotrexate
“The decision was made to prematurely discontinue this trial due to lack of efficacy.” - Compare Technegas Ventilation-Perfusion SPECT and Xenon Ventilation-Perfusion Planar Imaging for Pulmonary Embolism
“Decision to change trial design.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.